ChartMill assigns a Buy % Consensus number of 83% to RKDA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-14 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-26 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-03 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-01 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-11 | Lake Street | Initiate | Buy |
| 2021-02-09 | HC Wainwright & Co. | Maintains | Buy |
7 analysts have analysed RKDA and the average price target is 12.24 USD. This implies a price increase of 234.43% is expected in the next year compared to the current price of 3.66.
The consensus rating for ARCADIA BIOSCIENCES INC (RKDA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ARCADIA BIOSCIENCES INC (RKDA) is 7.